# Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C

> **NCT01018615** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 28 (actual)

## Conditions studied

- Chronic Hepatitis C
- Oxidative Stress

## Interventions

- **DRUG:** silymarin
- **DIETARY_SUPPLEMENT:** green tea extract (EGCG)

## Key facts

- **NCT ID:** NCT01018615
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2013-04
- **Final completion:** 2013-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018615, "Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01018615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*